Literature DB >> 1527304

Symptom-limited versus low level exercise testing before hospital discharge after myocardial infarction.

M Juneau1, P Colles, P Théroux, P de Guise, G Pelletier, J Lam, D Waters.   

Abstract

OBJECTIVE: This study was undertaken to compare a low level and a symptom-limited test performed before hospital discharge after an uncomplicated myocardial infarction.
BACKGROUND: Exercise testing after myocardial infarction provides useful prognostic information. Usually either a low level test is performed before hospital discharge or a symptom-limited test is performed at 3 weeks.
METHODS: The study group comprised 202 patients with an uncomplicated myocardial infarction; 58 patients had a non-Q wave infarction and 115 patients had received thrombolytic therapy. Both a low level and a symptom-limited exercise test were performed in 200 of the 202 study patients in randomized order on consecutive days, a mean of 7.4 +/- 2.3 days after infarction.
RESULTS: The symptom-limited test required a considerably greater effort than the low level test: exercise duration was 554 +/- 209 versus 389 +/- 125 s (p less than 0.0001), and peak work load was 5.7 +/- 1.8 versus 4.2 +/- 1.1 METs (p less than 0.0001). The peak heart rate was higher during the symptom-limited test (121 +/- 20 vs. 108 +/- 14 beats/min, p less than 0.0001), as was the rate-pressure product. The number of patients who developed ST segment depression greater than or equal to 1 mm increased from 56 during the low level test to 89 during the symptom-limited test (p less than 0.0001). ST segment depression greater than or equal to 2 mm occurred in 22 patients during the low level test and in 41 patients during the symptom-limited test, an 86% increase (p less than 0.0001). The number of patients with either angina or ST depression greater than or equal to 1 mm increased from 66 to 105 (p less than 0.0001) with the symptom-limited test. Exercise test results were similar for patients with a Q wave or a non-Q wave infarction. Exercise duration was longer and exercise-induced ST depression less frequent in patients who had received thrombolytic therapy.
CONCLUSIONS: A symptom-limited exercise test performed before hospital discharge after uncomplicated myocardial infarction provides a significantly greater cardiovascular stress than does a low level test and is associated with an ischemic response nearly twice as frequently. The prognostic significance of a positive response at higher work loads has not been defined.

Entities:  

Mesh:

Year:  1992        PMID: 1527304     DOI: 10.1016/0735-1097(92)90195-s

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

Review 1.  Peptide synthesis through evolution.

Authors:  K Tamura; R W Alexander
Journal:  Cell Mol Life Sci       Date:  2004-06       Impact factor: 9.261

Review 2.  [Complications during exercise testing].

Authors:  R Berent; J Auer; S P von Duvillard; H Sinzinger; P Schmid
Journal:  Herz       Date:  2011-11-17       Impact factor: 1.443

3.  Prediction of VO2 peak using OMNI Ratings of Perceived Exertion from a submaximal cycle exercise test.

Authors:  Ryan J Mays; Fredric L Goss; Elizabeth F Nagle; Michael Gallagher; Mark A Schafer; Kevin H Kim; Robert J Robertson
Journal:  Percept Mot Skills       Date:  2014-05-21

4.  Risk stratifying patients who survive an acute myocardial infarction.

Authors:  M S Verani
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

5.  Prognostic value of symptom limited versus low level exercise stress test before discharge in patients with myocardial infarction treated with thrombolytics.

Authors:  K Jensen-Urstad; B A Samad; F Bouvier; J Hulting; J Höjer; H Ruiz; M Jensen-Urstad
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

6.  Detection of multivessel disease post myocardial infarction using an exercise-induced QRS score.

Authors:  Andreas P Michaelides; Dimitris Papapetrou; Maria-Niki K Aigyptiadou; Zoi D Psomadaki; George K Andrikopoulos; Athanasios Kartalis; Christos Fourlas; Christodoulos I Stefanadis
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-07       Impact factor: 1.468

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.